Acasti Pharma Inc.
NASDAQ: ACST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Prashant Kohli
- Employees
- 32
- Headquarters
- Laval, Canada
- IPO year
- 2012
- Market cap
- $34.2M
- Website
- https://www.acastipharma.com
Loading ACST…
Loading profile data…Frequently asked questions about ACST
What does Acasti Pharma Inc. (ACST) do?
Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was est...
Where does ACST trade?
Acasti Pharma Inc. (ACST) trades on the NASDAQ Capital Market.
What sector is ACST in?
Acasti Pharma Inc. (ACST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Acasti Pharma Inc.?
Prashant Kohli is the chief executive officer of Acasti Pharma Inc. (ACST).
Where is Acasti Pharma Inc. headquartered?
Acasti Pharma Inc. is headquartered in Canada.
Does ACST pay a dividend?
Acasti Pharma Inc. (ACST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACST go public?
Acasti Pharma Inc. (ACST) completed its initial public offering in 2012.